Decreased ventral striatal activity with impulse control disorders in Parkinson's Disease

Movement Disorders

Volumn 25, Issue 11, 2010, Pages 1660-1669

  Rao, Hengyi ^a,b,c   Mamikonyan, Eugenia ^b   Detre, John A ^a   Siderowf, Andrew D ^a   Stern, Matthew B ^a,d   Potenza, Marc N ^e,f   Weintraub, Daniel ^a,b,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SOUTH CHINA NORMAL UNIVERSITY   (China)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Functional magnetic resonance imaging; Impulse control disorder; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD OXYGENATION; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIGH RISK BEHAVIOR; HUMAN; IMAGE ANALYSIS; IMPULSE CONTROL DISORDER; MALE; NEUROIMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERFORMANCE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; BASAL GANGLIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMPULSE CONTROL DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PARKINSON DISEASE; REST; TASK PERFORMANCE AND ANALYSIS;

EID: 77955835640     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23147     Document Type: Article

References (53)

1. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-973.
2. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-1257. (Pubitemid 44563838)
3. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21:524-529.
4. Weintraub D, Koester J, Potenza MN et al. Dopaminergic therapy and impulse control disorders in Parkinson's disease: a cross-sectional study of dopaminergic therapy and other clinical features in 3,090 patients. Arch Neurol (in press).
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fourth ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
6. Holden C. 'Behavioral' addictions: do they exist? Science 2001;294:980-982.
7. Ondo W, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008;14:28-32.
8. Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud 2009;25:425-431.
9. Hollander E, Evers M. New developments in impulsivity. Lancet 2001;358:949-950.
10. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009;56(Suppl 1):3-8.
11. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005;8:147-148.
12. Potenza MN, Leung H-C, Blumberg HP, et al. An fMRI Stroop task study in ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003;160:1990-1994.
13. Potenza MN. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008;363:3181-3189.
14. Lejuez CW, Read JP, Kahler CW, et al. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl 2002;8:75-84.
15. Rao H, Korczykowski M, Pluta J, Hoang A, Detre JA. Neural correlates of voluntary and involuntary risk taking in the human brain: an fMRI Study of the Balloon Analog Risk Task BART). NeuroImage 2008;42:902-910.
16. Lejuez CW, Aklin WM, Jones HA, et al. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol 2003;11:26-33.
17. Hunt MK, Hopko DR, Bare R, Lejuez CW, Robinson EV. Construct validity of the Balloon Analog Risk Task (BART): associations with psychopathy and impulsivity. Assessment 2005;12:416-428.
18. Van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 2009;34:2758-2766.
19. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45.
20. Detre JA, Wang J. Technical aspects and utility of fMRI using BOLD and ASL. Clin Neurophysiol 2002;113:621-634.
21. Raichle ME. Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci USA 1998;95:765-772.
22. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93-100.
23. Shaffer HJ, LaBrie R, Scanlan KM, Cummings TN. Pathological gambling among adolescents: Massachusetts gambling screen (MAGS). J Gambl Stud 1994;10:339-362.
24. Christenson GA, Faber RJ, deZwaan M. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994;55:5-11.
25. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJL. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-428.
26. Fahn S, Elton RL,the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information; 1987. p153-163.
27. Hobson P, Gallacher J, Meara J. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom. Mov Disord 2005;20:995-998.
28. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, editor. Clinical gerontology: a guide to assessment and intervention. New York: The Haworth Press; 1986. p165-173.
29. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
30. Fernandez-Seara MA, Edlow BL, Hoang A, Wang J, Feinberg DA, Detre JA. Minimizing acquisition time of arterial spin labeling at 3T. Magn Reson Med 2008;59:1467-1471.
31. Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA. Amplitude modulated continuous arterial spin labeling perfusion MR imaging with single coil at 3.0 Tesla. Radiology 2005;235:218-228.
32. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 2002;15:870-878.
33. Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science 2007;315:515-518.
34. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 2008;75:63-75.
35. 11C raclopride PET study. Brain 2009;132:1376-1385.
36. Cilia R, Siri C, Marotta G, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 2008;65:1604-1611.
37. Brand M, Labudda K, Kalbe E, et al. Decision-making impairments in patients with Parkinson's disease. Behav Neurol 2004;15:77-85.
38. Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1430-1435.
39. Kobayakawa M, Koyama S, Mimura M, Kawamura M. Decision making in Parkinson's disease: analysis of behavioral and physiological patterns in the Iowa gambling task. Mov Disord 2008;23:547-552.
40. Künig G, Leenders KL, Martin-Sölch C, Missimer J, Magyar S, Schultz W. Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 2000;11:3681-3687.
41. Thiel A, Hilker R, Kessler J, Habedank B, Herholz K, Heiss WD. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Transm 2003;110:1289-1301.
42. Schott BH, Niehaus L, Wittmann BC, et al. Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing. Brain 2007;130:2412-2424.
43. Evans AH, Lawrence AD, Lees AJ. Changes in psychomotor effects of L-dopa and methyphenidate after sustained dopaminergic therapy in Parkinson disease. J Neurol Neurosurg Psychiatry 2009;80:267-272.
44. Bódi N, Kéri S, Nagy H et al. Reward-learning and the novelty seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009;132:2385-2395.
45. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309-1312.
46. Cools R. Dopaminergic modulation of cognitive function - implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.
47. Mamikonyan E, Siderowf AD, Duda JE, et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 2008;23:75-80; PMCID: PMC17960796.
48. Grant JE, Potenza MN, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006;163:303-312.
49. Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 2008;69:783-789.
50. Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998;59:159-164.
51. Voon V, Pessiglione M, Brezing C, et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010;65:135-142.
52. Delgado MR, Schotter A, Ozbay EY, Phelps EA. Understanding overbidding: using the neural circuitry of reward to design economic auctions. Science 2010;321:1849-1852.
53. Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum MS. Imaging monetary reward in pathological gamblers. World J Biol Psychiatry 2005;6:113-120.